AU2001235829A1 - Mutations in spink5 responsible for netherton's syndrome and atopic diseases - Google Patents

Mutations in spink5 responsible for netherton's syndrome and atopic diseases

Info

Publication number
AU2001235829A1
AU2001235829A1 AU2001235829A AU3582901A AU2001235829A1 AU 2001235829 A1 AU2001235829 A1 AU 2001235829A1 AU 2001235829 A AU2001235829 A AU 2001235829A AU 3582901 A AU3582901 A AU 3582901A AU 2001235829 A1 AU2001235829 A1 AU 2001235829A1
Authority
AU
Australia
Prior art keywords
spink5
netherton
mutations
syndrome
responsible
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001235829A
Inventor
Stephane Chavanas
William Cookson
Alain Hovnanian
Miriam Moffat
Andrew Walley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford University Innovation Ltd
Original Assignee
Oxford University Innovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0005098A external-priority patent/GB0005098D0/en
Priority claimed from GB0005229A external-priority patent/GB0005229D0/en
Application filed by Oxford University Innovation Ltd filed Critical Oxford University Innovation Ltd
Publication of AU2001235829A1 publication Critical patent/AU2001235829A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8135—Kazal type inhibitors, e.g. pancreatic secretory inhibitor, ovomucoid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AU2001235829A 2000-03-02 2001-03-02 Mutations in spink5 responsible for netherton's syndrome and atopic diseases Abandoned AU2001235829A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0005098A GB0005098D0 (en) 2000-03-02 2000-03-02 Disease gene
GB0005098 2000-03-02
GB0005229 2000-03-03
GB0005229A GB0005229D0 (en) 2000-03-03 2000-03-03 Disease gene
PCT/GB2001/000897 WO2001064747A1 (en) 2000-03-02 2001-03-02 Mutations in spink5 responsible for netherton's syndrome and atopic diseases

Publications (1)

Publication Number Publication Date
AU2001235829A1 true AU2001235829A1 (en) 2001-09-12

Family

ID=26243786

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001235829A Abandoned AU2001235829A1 (en) 2000-03-02 2001-03-02 Mutations in spink5 responsible for netherton's syndrome and atopic diseases

Country Status (4)

Country Link
US (1) US20030190637A1 (en)
EP (1) EP1294768A1 (en)
AU (1) AU2001235829A1 (en)
WO (1) WO2001064747A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002066513A2 (en) * 2001-02-19 2002-08-29 Ipf Pharmaceuticals Gmbh Human circulating lekti fragments hf7072, hf7638 and hf14448 and use thereof
AU2003210317A1 (en) * 2002-02-22 2003-09-09 Ipf Pharmaceuticals Gmbh Novel compound for inhibiting serine proteases and for inhibiting viral infections or viral propagation: rld 8564
SG11201909048TA (en) * 2017-04-21 2019-11-28 Genentech Inc Use of klk5 antagonists for treatment of a disease
EP3638369A4 (en) * 2017-06-16 2021-03-17 Azitra, Inc. Compositions and methods for treatment of netherton syndrome with lekti expressing recombinant microbes
EP3856761A1 (en) 2018-09-24 2021-08-04 Krystal Biotech, Inc. Compositions and methods for the treatment of netherton syndrome

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5900400A (en) * 1984-12-06 1999-05-04 Amgen Inc. Serine protease inhibitor analogs
US5000000A (en) * 1988-08-31 1991-03-19 University Of Florida Ethanol production by Escherichia coli strains co-expressing Zymomonas PDC and ADH genes
US5346886A (en) * 1993-11-15 1994-09-13 John Lezdey Topical α-1-antitrypsin, non-aqueous lipid miscible, benzalkonium chloride compositions for treating skin
US7045594B1 (en) * 1997-12-23 2006-05-16 Pharis Biotec Gmbh Serine proteinase inhibitors
CA2375475C (en) * 1999-06-22 2014-10-14 Forssmann, Wolf-Georg Serine proteinase inhibitors

Also Published As

Publication number Publication date
US20030190637A1 (en) 2003-10-09
WO2001064747A1 (en) 2001-09-07
EP1294768A1 (en) 2003-03-26

Similar Documents

Publication Publication Date Title
AU2002225356A1 (en) Glucopyranosyloxypyrazole derivatives and use thereof in medicines
AU2001235275A1 (en) Adjustable chair
HUS1300012I1 (en) Soluble ctla4 mutant molecules and uses thereof
AU2001213236A1 (en) Mini-cyclone biocollector and concentrator
AU3804297A (en) Chair for use in construction
AU715620C (en) Therapeutic methods and uses
AU2001272011A1 (en) Siderophores-producing bifidobacteria thereby and uses thereof
AU3472799A (en) Dermatological formulations and methods
CY2291B1 (en) 1H-pyridoa3,4-buindole-4-carboxamide derivatives preparation and application thereof in therapeutics
AU2001229439A1 (en) Bioconjugates and uses thereof
AU2001235829A1 (en) Mutations in spink5 responsible for netherton's syndrome and atopic diseases
AU2001261375A1 (en) Human caspase-12 materials and methods
AU2529799A (en) Benzofuran-4-carboxamides and their therapeutic use
AU4432001A (en) Trityl-type compounds and their use
AU2001235364A1 (en) Tetrahydronaphtalene derivatives and their use
AU2669201A (en) Taccalonolides and their use
AU2002256556A1 (en) Sea-trosy and related methods
AU2001263287A1 (en) Human protein kinase "13305" and uses therefor
AU5974100A (en) 6-carboxyphenyldihydropyridazinone derivatives and use thereof
AU6150400A (en) Tetrahydroquinolinyl-6-methyldihydrothiadiazinone derivatives and use thereof
AU2001231917A1 (en) Isolated complex comprising a nnt-1 protein and in addition at least a clf-1 protein and/or a scntfralpha protein
AU5817700A (en) Detectors and their use
AU2001241928A1 (en) Transferase 32253 and use therefor
AU5005099A (en) Benzoquinolizidine and benzoindolizidine derivatives and therapeutic uses thereof
AU2001285370A1 (en) 50566, human glyoxalase ii related factor and uses thereof